EUVIMEDEUVIMED entdecken
Crossref

Irisin Ameliorates Muscle Atrophy by Inhibiting the Upregulation of the Ubiquitin‒Proteasome System in Chronic Kidney Disease

Shiyuan Wang, Yajing Pan, Qi Pang, Aihua Zhang iD

Calcified Tissue International · 2024

DOI: 10.1007/s00223-024-01283-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Calcified Tissue International, 2024. Verfasst von Shiyuan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Xuanwu Hospital Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 10000, China. Hauptthemen laut MEDLINE: Fibronectins, Muscular Atrophy, Proteasome Endopeptidase Complex, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Beijing Municipal Commission of Education, National Natural Science Foundation of China, Huizhi Talents Leading Cultivation Program of Xuanwu Hospital of Capital Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Muscle atrophy is a common complication of chronic kidney disease (CKD). Irisin, a novel muscle cytokine, protects against muscle atrophy, but its specific role in CKD-associated muscle atrophy requires further elucidation. Because the ubiquitin-proteasome system (UPS) plays an important role in CKD muscle atrophy, our study will explore whether irisin affects UPS and alleviate CKD-associated muscle atrophy. In this study, an adenine-fed mouse model of CKD and urotension II (UII)-induced C2C12 myotubes were used as in vivo and in vitro models of muscle atrophy. The results showed that renal function, mouse weight, and the cross-sectional area (CSA) of skeletal muscles were significantly improved in CKD mice treated with irisin. Moreover, irisin effectively mitigated the decreases in phosphorylated Forkhead box O 3a (p-FOXO3A) levels and increases in the levels of E3 ubiquitin ligases, such as muscle RING finger 1 (MuRF1) and muscle atrophy F-box (MAFbx/atrogin1), in both the muscles of CKD mice and UII-induced C2C12 myotubes. In addition, irisin significantly increased the expression levels of myogenic differentiation factor D (MyoD) in the muscles of CKD mice. Our study is the first to demonstrate that irisin ameliorates skeletal muscle atrophy by inhibiting UPS upregulation and improving satellite cell differentiation in CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibronectinsMuscular AtrophyProteasome Endopeptidase ComplexRenal Insufficiency, ChronicUbiquitinAnimalsMaleMiceMice, Inbred C57BLMuscle Fibers, SkeletalMuscle, SkeletalUp-Regulation

Stichwörter der Autor:innen

Chronic kidney diseaseIrisinSkeletal muscle atrophyUbiquitin proteasome systemUrotension II

Substanzen

FibronectinsFNDC5 protein, mouseProteasome Endopeptidase ComplexUbiquitin

Autor:innen und Institutionen

  • Department of Nephrology, Xuanwu Hospital Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 10000, China.
  • Department of Nephrology, Xuanwu Hospital Capital Medical University, 45 Changchun Street, Xicheng District, Beijing, 10000, China. zhangaihua0982@sina.com.

ORCID-Profile: Aihua Zhang

Förderung

  • Beijing Municipal Commission of Education
  • National Natural Science Foundation of China
  • Huizhi Talents Leading Cultivation Program of Xuanwu Hospital of Capital Medical University

Zitieren

APA

Wang, S., Pan, Y., Pang, Q., & Zhang, A. (2024). Irisin Ameliorates Muscle Atrophy by Inhibiting the Upregulation of the Ubiquitin‒Proteasome System in Chronic Kidney Disease. Calcified Tissue International. https://doi.org/10.1007/s00223-024-01283-4

Vancouver

Wang S, Pan Y, Pang Q, Zhang A. Irisin Ameliorates Muscle Atrophy by Inhibiting the Upregulation of the Ubiquitin‒Proteasome System in Chronic Kidney Disease. Calcified Tissue International. 2024. doi:10.1007/s00223-024-01283-4

BibTeX
@article{Wang2024,
  author = {Wang, Shiyuan and Pan, Yajing and Pang, Qi and Zhang, Aihua},
  title = {Irisin Ameliorates Muscle Atrophy by Inhibiting the Upregulation of the Ubiquitin‒Proteasome System in Chronic Kidney Disease},
  journal = {Calcified Tissue International},
  year = {2024},
  doi = {10.1007/s00223-024-01283-4}
}
Kostenlos starten →